Immune Thrombocytopenia
Conditions
Interventions
Intervention Group:Conventional treatment + Tonglaga 601
Patients in the experimental group receive the intervention of combined conventional treatment and Tonglaga 601. The conventional treatment regimen is: Initially give an intravenous drip of dexamethas
Control Group:Conventional treatment + Simulant of Tonglaga-601
Patients in the control group receive the intervention of combined conventional treatment and the simulant of Tonglaga 601. The conventional treatment regimen is: Initially give an intravenous drip of
Sponsors
Inner Mongolia International Mongolian Medical Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed Western medical diagnosis of immune thrombocytopenia (ITP), with a platelet (PLT) count < 30×109/L or presence of bleeding symptoms. 2. Adult patients aged 18 to 75 years. 3. Patients who used immunosuppressants such as Cyclosporine A, Vincristine, and Azathioprine prior to consultation may be included after completing a washout period (Cyclosporine A: 10-16 hours; Vincristine: 27 hours; Azathioprine: 5-10 hours). 4. Patients who provide informed consent, voluntarily participate in the study, and commit to taking medications regularly.
Exclusion criteria
Exclusion criteria: (1) Patients who received high-dose glucocorticoid pulse therapy during the first 3 months before seeking medical attention; (2) Patients with severe immune deficiency; (3) Patients with severe heart liver and kidney dysfunction; (4) Patients who cannot accept or tolerate medication treatment; (5) Those who cannot use medication according to regulations have poor compliance cannot determine efficacy or have incomplete information that affects efficacy and safety judgment; (6) Those who have received relevant treatment and may have an impact on the efficacy observation indicators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effective rate of platelets;Bleeding Score Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Platelet Count;Fatigue Scoring Table; | — |
Countries
China
Contacts
Public ContactChen shana
Inner Mongolia International Mongolian Medical Hospital
Outcome results
None listed